Author

Priyadarshini Gangidi

Institution: Osmania University

Observed institution: Osmania University

ORCID: 0009-0003-4291-859X

Observed ORCID: 0009-0003-4291-859X

OpenAlex ID: A5119680993

An In Silico Design, Simulation, Virtual Screening, and Evaluation of Natural Products as Inhibitors of Breast Cancer-Causing Kallikrein11 Protein and Comparison of Binding Affinities with Approved Drugs

2026 · Vani Kondaparthi, Vasavi Malkhed, et al. · Current Drug Targets

Application Of in Silico Drug Design Approaches as A Channel to Uncover Strong Inhibitors of The MYL5 Protein Implicated in Cervical Cancer

2024 · Priyadarshini Gangidi · African Journal of Biomedical Research

Identification of Small Ligand Molecules as Potent Inhibitors of the Myl9 Protein: as Future Cancer Leads.

2024 · Priyadarshini Gangidi

Works count: 3

Citation count:

H-index:

I10-index: